Security
Scilex Holding Company Common Stock · SCLX
SCLXNASDAQCommon stockCurrentCIK 1820190Updated Oct 6, 2026
Name history
Scilex Holding Company/DE · through Nov 30, 2022Vickers Vantage Corp. I · through Nov 15, 2022
SCLX price & chart
Loading TradingView…
NASDAQ:SCLX on TradingView ↗About the company
Scilex is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease. Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and is dedicated to advancing and improving patient outcomes. Scilex’s commercial products include: (i) ZTlido® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the relief of neuropathic pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain; (ii) ELYXYB®, a
In the news
Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026 ↗
Recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
10-Q filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets
Items 1.01, 2.01, 9.01
SCHEDULE 13D/A - filed by SCLX Stock Acquisition JV LLC regarding Scilex Holding Co
Show 5 more recent filings
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
S-8 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02
SCHEDULE 13D/A - filed by Scilex Holding Co regarding Semnur Pharmaceuticals, Inc.
Submission of Matters to a Vote of Security Holders
Items 5.07, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 275,879,000Source | 100,430,000Source | 253,562,000Source | 83,755,000Source | 104,544,000Source | 293,635,000Source | 78,976,000Source | 91,240,000Source | 364,981,000Source | 92,953,000Source | 101,309,000Source | 86,527,000Source |
| Property, Plant and Equipment, NetUSD | 703,000Source | 711,000Source | 12,766,000Source | 705,000Source | 714,000Source | 13,379,000Source | 707,000Source | 718,000Source | 13,599,000Source | 708,000Source | 722,000Source | 772,000Source |
| GoodwillUSD | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 30,422,000Source | 33,454,000Source | 57,611,000Source | 31,443,000Source | 34,456,000Source | 59,807,000Source | 31,451,000Source | 35,458,000Source | 59,088,000Source | 32,453,000Source | 36,485,000Source | 40,591,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 878,000Source | 77,000Source | 566,000Source | 4,099,000Source | 6,888,000Source | 3,351,000Source | 5,800,000Source | 1,818,000Source | 4,955,000Source | 3,272,000Source | 3,921,000Source | 2,184,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 11,941,000Source | 31,580,000Source | 6,439,000Source | 16,767,000Source | 38,004,000Source | 10,647,000Source | 10,619,000Source | 29,716,000Source | 15,244,000Source | 26,442,000Source | 34,597,000Source | 21,236,000Source |
| Inventory, NetUSD | 1,082,000Source | 2,404,000Source | 4,171,000Source | 2,519,000Source | 3,073,000Source | 4,532,000Source | 3,017,000Source | 3,486,000Source | 4,789,000Source | 2,436,000Source | 4,214,000Source | 1,378,000Source |
| Assets, CurrentUSD | 16,487,000Source | 39,855,000Source | 36,235,000Source | 33,671,000Source | 50,418,000Source | 41,970,000Source | 28,704,000Source | 37,745,000Source | 38,358,000Source | 41,547,000Source | 46,781,000Source | 29,608,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,683,000Source | 2,396,000Source | 14,047,000Source | 1,868,000Source | 2,578,000Source | 14,175,000Source | 2,049,000Source | 2,763,000Source | 14,818,000Source | 2,225,000Source | 2,943,000Source | 1,131,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 455,598,000Source | 311,747,000Source | 564,050,000Source | 332,742,000Source | 319,236,000Source | 547,705,000Source | 290,460,000Source | 281,026,000Source | 576,733,000Source | 285,594,000Source | 274,247,000Source | 50,288,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | — | — | 0Source | — | — | 0Source | — | — | 0Source | 3,000Source |
| Common Stock, Value, IssuedUSD | 1,000Source | 19,000Source | 1,000Source | 1,000Source | 18,000Source | 1,000Source | 1,000Source | 17,000Source | 1,000Source | 24,000Source | 16,000Source | 14,000Source |
| Additional Paid in CapitalUSD | 785,304,000Source | 430,767,000Source | 854,130,000Source | 453,049,000Source | 426,165,000Source | 799,301,000Source | 448,244,000Source | 415,341,000Source | 796,721,000Source | 454,591,000Source | 407,813,000Source | 412,136,000Source |
| Retained Earnings (Accumulated Deficit)USD | -888,674,000Source | -556,592,000Source | -1,078,556,000Source | -631,440,000Source | -552,204,000Source | -965,056,000Source | -589,132,000Source | -514,622,000Source | -921,786,000Source | -563,052,000Source | -490,245,000Source | -375,914,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 3,347,000Source | 5,011,000Source | -6,982,000Source | 6,317,000Source | 1,851,000Source | -6,550,000Source | 6,317,000Source | — | -5,803,000Source | 6,317,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | -176,936,000Source | -211,317,000Source | -308,322,000Source | -248,987,000Source | -214,692,000Source | -249,219,000Source | -211,484,000Source | -189,786,000Source | -207,781,000Source | -192,641,000Source | -172,938,000Source | 36,239,000Source |
| Liabilities and EquityUSD | 275,879,000Source | 100,430,000Source | 253,562,000Source | 83,755,000Source | 104,544,000Source | 293,635,000Source | 78,976,000Source | 91,240,000Source | 364,981,000Source | 92,953,000Source | 101,309,000Source | 86,527,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 358,948,000Source | 281,537,000Source | 512,242,000Source | 305,932,000Source | 255,451,000Source | 501,752,000Source | 275,744,000Source | 252,732,000Source | 483,652,000Source | 259,635,000Source | 250,380,000Source | 44,842,000Source |
| Operating Lease, Liability, CurrentUSD | 796,000Source | 688,000Source | 2,241,000Source | 768,000Source | 701,000Source | 1,723,000Source | 740,000Source | 731,000Source | 1,733,000Source | 714,000Source | 759,000Source | 745,000Source |
| Accounts Payable, CurrentUSD | 67,362,000Source | 43,400,000Source | 121,050,000Source | 59,155,000Source | 41,787,000Source | 101,578,000Source | 57,257,000Source | 42,219,000Source | 86,266,000Source | 52,620,000Source | 40,954,000Source | 8,450,000Source |
| Operating Lease, Liability, NoncurrentUSD | 918,000Source | 1,714,000Source | 12,509,000Source | 1,126,000Source | 1,893,000Source | 12,686,000Source | 1,327,000Source | 2,068,000Source | 13,151,000Source | 1,523,000Source | 2,237,000Source | 665,000Source |
| Other Liabilities, NoncurrentUSD | 169,000Source | 155,000Source | 180,000Source | 165,000Source | 187,000Source | 177,000Source | 155,000Source | 182,000Source | 174,000Source | 155,000Source | 179,000Source | 163,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -2,783,000Source | — | -2,166,000Source | — | — | -4,851,000Source | — | — | -3,971,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 17,413,000Source | 2,997,000Source | 3,494,000Source | 2,919,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Accrued Liabilities, Current | —Source | — | — | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -4,388,000Source | -114,986,000Source | -44,048,000Source | — | -26,080,000Source | — | -72,807,000Source | -114,331,000Source | -23,364,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 2,869,000Source | 1,003,000Source | 4,623,000Source | 4,046,000Source | 4,146,000Source | 3,961,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 3,256,000Source | 3,713,000Source | — | — | 3,629,000Source | 3,314,000Source | 15,492,000Source | 15,689,000Source | 14,596,000Source | 5,280,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -4,597,000Source | -15,823,000Source | -13,837,000Source | 6,267,000Source | 13,361,000Source | 6,968,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -257,000Source | 584,000Source | -1,799,000Source | -1,462,000Source | 2,838,000Source | -1,184,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 13,567,000Source | -19,082,000Source | -27,761,000Source | -12,247,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,107,000Source | 6,007,000Source | 3,816,000Source | 19,349,000Source | -20,707,000Source | -21,258,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -9,160,000Source | -395,000Source | 4,084,000Source | -2,675,000Source | -330,000Source | -2,067,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 133,000Source | 0Source | 30,000Source | 7,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 9,144,000Source | -3,084,000Source | -5,461,000Source | -18,131,000Source | 23,582,000Source | 21,171,000Source |
| Dividends paid | — | — | — | — | — | — | — | — | — | —Source | —Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,604,000Source | 2,528,000Source | 1,683,000Source | -1,457,000Source | 2,545,000Source | -2,154,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 878,000Source | 8,116,000Source | 566,000Source | 4,099,000Source | 3,351,000Source | 5,800,000Source | 4,955,000Source | 3,272,000Source | 4,729,000Source | 2,184,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 21,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | -481,000Source | 0Source | -756,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 3,713,000Source | — | — | — | — | — | 15,689,000Source | 14,596,000Source | 5,280,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 1,028,000Source | 0Source | 409,000Source | 316,000Source | 65,000Source | 3,142,000Source |
| Amortization of Intangible AssetsUSD | — | — | 1,020,000Source | 1,002,000Source | 2,092,000Source | 1,008,000Source | 2,092,000Source | 1,002,000Source | 4,364,000Source | 4,031,000Source | 4,106,000Source | 3,922,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | — | — | 5,000Source | 0Source | -3,071,000Source | 0Source | -199,000Source | — | — | — |
| DepreciationUSD | — | — | 2,000Source | 4,000Source | 800,000Source | 2,000Source | 800,000Source | 1,000Source | 258,900Source | 14,000Source | 40,000Source | 40,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -58,357,000Source | 18,108,000Source | -6,644,000Source | -12,375,000Source | 25,709,000Source | 10,409,000Source | -22,693,000Source | 17,378,000Source | -512,000Source | 8,310,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -2,000Source | -46,000Source | -150,000Source | -99,000Source | -279,000Source | 4,000Source | 86,000Source | -45,000Source | -118,000Source | -66,000Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | — | — | 4,702,000Source | 0Source | -9,258,000Source | 0Source | -18,064,000Source | 0Source | -12,180,000Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | — | — | — | — | 42,338,000Source | 0Source | 19,218,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | -7,350,000Source | — | 0Source | 28,634,000Source |
| GoodwillUSD | — | — | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source | 13,481,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | 0Source | 0Source | 73,400,000Source | 0Source | 0Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 73,358,000Source | — | — | — |
| Income (Loss) from Equity Method Investments, Net of Dividends or DistributionsUSD | — | — | — | — | -50,737,000Source | 0Source | -31,710,000Source | 0Source | 54,760,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 1,000Source | 0Source | 7,000Source | 19,000Source | — | — | 26,000Source | -1,000Source | 13,000Source | 4,000Source |
| InterestExpenseNonoperatingUSD | — | — | 2,798,000Source | 576,000Source | 6,104,000Source | 2,682,000Source | 3,779,000Source | 2,481,000Source | 11,459,000Source | 1,963,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -257,820,000Source | -4,388,000Source | -114,986,000Source | -44,048,000Source | -45,650,000Source | -26,080,000Source | -374,053,000Source | -72,807,000Source | -114,331,000Source | -23,364,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | -1,486,000Source | -1,740,000Source | — | — | 11,800,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -257,234,000Source | -4,388,000Source | -114,729,000Source | -86,061,000Source | -43,270,000Source | -26,080,000Source | -402,487,000Source | -72,807,000Source | -166,976,000Source | — |
| Nonoperating Income (Expense)USD | — | — | -71,307,000Source | 15,529,000Source | -85,556,000Source | -23,522,000Source | -13,481,000Source | 1,818,000Source | -28,020,000Source | 10,588,000Source | -8,887,000Source | 27,274,000Source |
| Operating Costs and ExpensesUSD | — | — | 197,072,000Source | 34,353,000Source | 37,065,000Source | 30,403,000Source | 40,782,000Source | 32,902,000Source | 376,260,000Source | 139,986,000Source | 152,174,000Source | 88,668,000Source |
| Operating Lease, ExpenseUSD | — | — | 300,000Source | 300,000Source | 1,100,000Source | 200,000Source | 1,200,000Source | 300,000Source | 1,200,000Source | 1,000,000Source | 1,100,000Source | — |
| Payments for Repurchase of WarrantsUSD | — | — | — | 298,000Source | — | — | — | — | 27,000,000Source | 300,000Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | 35,458,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | 0Source | 23,000Source | 2,113,000Source | 1,135,000Source | 96,000Source |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | — | 19,218,000Source | — | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | 8,282,000Source | 0Source | — | — | -31,710,000Source | 0Source | 2,692,000Source | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Provision for Loan, Lease, and Other Losses | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 10,560,000Source | 14,436,000Source | 7,642,000Source | 9,896,000Source | 8,613,000Source | 5,004,000Source | 30,253,000Source | 56,590,000Source | 46,743,000Source | 38,034,000Source |
| Cost of RevenueUSD | — | — | 3,329,000Source | 3,768,000Source | 8,119,000Source | 29,642,000Source | 17,121,000Source | 12,699,000Source | 96,262,000Source | 16,689,000Source | 15,681,000Source | 10,797,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 188,824,000Source | 29,734,000Source | 27,960,000Source | 19,841,000Source | 31,033,000Source | 28,060,000Source | 266,884,000Source | 119,016,000Source | 119,641,000Source | 64,895,000Source |
| Operating Income (Loss)USD | — | — | -186,512,000Source | -19,917,000Source | -29,423,000Source | -20,507,000Source | -32,169,000Source | -27,898,000Source | -346,007,000Source | -83,396,000Source | -105,431,000Source | -50,634,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -257,819,000Source | -4,388,000Source | -114,979,000Source | -44,029,000Source | -45,650,000Source | -26,080,000Source | -374,027,000Source | -72,808,000Source | -114,318,000Source | -23,360,000Source |
| Income Tax Expense (Benefit)USD | — | — | 1,000Source | 0Source | 7,000Source | 19,000Source | — | — | 26,000Source | -1,000Source | 13,000Source | 4,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | — | — | -1,486,000Source | -1,740,000Source | — | — | 11,800,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -257,820,000Source | -4,388,000Source | -114,986,000Source | -44,048,000Source | -45,650,000Source | -26,080,000Source | -374,053,000Source | -72,807,000Source | -114,331,000Source | -23,364,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -22.17Source | -0.58Source | -16.65Source | -7.42Source | -6.28Source | -2.26Source | -36.48Source | -0.56Source | -1.28Source | -0.17Source |
| Earnings Per Share, DilutedUSD per share | — | — | -22.17Source | -0.58Source | -16.65Source | -7.42Source | -6.28Source | -2.26Source | -36.48Source | -0.61Source | -1.28Source | -0.17Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 11,604Source | 7,557Source | 6,892,000Source | 11,595,000Source | 6,891,000Source | 11,565,000Source | 11,034Source | 131,136,000Source | 130,298,000Source | 134,226Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 11,604Source | 7,557Source | 6,892,000Source | 11,595,000Source | 6,891,000Source | 11,565,000Source | 11,034Source | 134,075,000Source | 130,298,000Source | 134,226Source |
| Interest Expense (non-operating)USD | — | — | 2,798,000Source | 576,000Source | 6,104,000Source | 2,682,000Source | 3,779,000Source | 2,481,000Source | 11,459,000Source | 1,963,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 1,020,000Source | 1,002,000Source | 2,092,000Source | 1,008,000Source | 2,092,000Source | 1,002,000Source | 4,364,000Source | 4,031,000Source | 4,106,000Source | 3,922,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 26,000Source | -1,000Source | 13,000Source | 4,000Source |
| Debt Securities, Realized Gain (Loss)USD | — | — | — | — | 5,000Source | 0Source | -3,071,000Source | 0Source | -199,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -2,000Source | -46,000Source | -150,000Source | -99,000Source | -279,000Source | 4,000Source | 86,000Source | -45,000Source | -118,000Source | -66,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 73,358,000Source | — | — | — |
| Gross ProfitUSD | — | — | — | — | 15,800,000Source | 39,500,000Source | 25,700,000Source | 17,700,000Source | 125,800,000Source | — | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 1,068,000Source | 9,604,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -257,234,000Source | -4,388,000Source | -114,729,000Source | -86,061,000Source | -43,270,000Source | -26,080,000Source | -402,487,000Source | -72,807,000Source | -166,976,000Source | — |
| Nonoperating Income (Expense)USD | — | — | -71,307,000Source | 15,529,000Source | -85,556,000Source | -23,522,000Source | -13,481,000Source | 1,818,000Source | -28,020,000Source | 10,588,000Source | -8,887,000Source | 27,274,000Source |
| Operating Costs and ExpensesUSD | — | — | 197,072,000Source | 34,353,000Source | 37,065,000Source | 30,403,000Source | 40,782,000Source | 32,902,000Source | 376,260,000Source | 139,986,000Source | 152,174,000Source | 88,668,000Source |
| Operating Lease, ExpenseUSD | — | — | 300,000Source | 300,000Source | 1,100,000Source | 200,000Source | 1,200,000Source | 300,000Source | 1,200,000Source | 1,000,000Source | 1,100,000Source | — |
| Realized Investment Gains (Losses)USD | — | — | — | — | — | — | — | — | 19,218,000Source | — | — | — |
| Research and Development ExpenseUSD | — | — | 3,899,000Source | 2,349,000Source | 3,336,000Source | 6,187,000Source | 3,210,000Source | 2,456,000Source | 20,710,000Source | 9,641,000Source | 12,746,000Source | 9,054,000Source |
| Selling ExpenseUSD | — | — | — | — | — | — | 72,000Source | — | 72,000Source | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-296430
Registration 333-295109
Filing attachments
sclx-ex99_1.htm · 8-K · 2026-07-06
EX-99.1 2 sclx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE July 6, 2026 Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP PALO ALTO, CALIFORNIA - July 6, 2026 (GLOBE NEWSWIRE) - Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treat…
Read attachment ↗sclx-ex4_4.htm · S-8 · 2026-06-30
SCILEX HOLDING COMPANY 2022 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: OCTOBER 17, 2022 APPROVED BY THE STOCKHOLDERS: NOVEMBER 9, 2022 EFFECTIVE DATE: NOVEMBER 9, 2022 AS AMENDED BY THE BOARD OF DIRECTORS ON: MARCH 5, 2023 Amendment Approved BY THE STOCKHOLDERS ON: MAY 4, 2023 AS AMENDED BY THE BOARD OF DIRECTORS ON: APRIL 28, 2026 Amendment Approved BY THE STOCKHOLDERS ON: June 24, 2026 GENERAL. (a) Plan Purpose. The Company, by means of the Plan, seeks to secure and r…
Read attachment ↗sclx-ex4_21.htm · 10-Q · 2026-05-20
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES IN THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPIN…
Read attachment ↗sclx-ex99_1.htm · 8-K · 2026-05-11
EX-99.1 2 sclx-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Dear Scilex Holding Company Stockholders and other holders of Scilex Holding Company Securities: This letter is being furnished to you as a holder of certain securities of Scilex Holding Company, a Delaware corporation (the “Company”). As the Company previously announced, its board of directors (the “Board”) declared a dividend (the “Dividend”) of Dream Bowl Meme Coin I tokens held by the Company (such tokens, the “Dream Bowl Tokens”)…
Read attachment ↗sclx-ex99_2.htm · 8-K · 2026-05-11
EX-99.2 3 sclx-ex99_2.htm EX-99.2 EX-99.2 Exhibit 99.2 Form of Scilex Holding Company Opt-In Agreement The undersigned (“me” or “I”) understands that Scilex Holding Company, a Delaware corporation (the “Company”), declared a dividend (the “Dividend”) of Dream Bowl Meme Coin I tokens (such tokens, the “Dream Bowl Tokens”) to the holders of the following Company securities, in each case as of the close of business on April 30, 2026 (such date, subject to the right of the Company’s board of …
Read attachment ↗sclx-ex99_1.htm · 8-K · 2026-05-05
EX-99.1 2 sclx-ex99_1.htm EX-99.1 EX-99.1 FOR IMMEDIATE RELEASE May 6, 2026 Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited PALO ALTO, CALIFORNIA - May 6, 2026 (GLOBE NEWSWIRE) - Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management pro…
Read attachment ↗